Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: jackie who wrote (2252)	8/28/1998 12:44:00 AM
From: tom jones	Read Replies (1) \| Respond to of 4676

To All: "Vitravene(TM) is indicated for the local treatment of CMV retinitis in patients with AIDS who are intolerant of or have a contraindication to other treatments for CMV retinitis or who were insufficiently responsive to previous treatments for CMV retinitis." This is from Isis press release: biz.yahoo.com I thought the committee approved Vitravene for all indications of CMV retinitis. Did something change or did I get something wrong? Comments? Tom